Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Ford

Showing results (441-450 of 458) with videos related to

Pageof 46
Sort By:
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
The Lancet. HIV|October 2, 2015
Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysisEdward J Mills, Richard Lester, Kristian Thorlund, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIVGabriela Patten, Karen Malateste, Carolyn Bolton Moore, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
Lancet (London, England)|August 4, 2012
Technologies for global healthPeter Howitt, Ara Darzi, Guang-Zhong Yang, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
The Lancet. HIV|December 2, 2021
Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countriesWin Min Han, Matthew G Law, Matthias Egger, et al.
Journal of the International AIDS Society|June 21, 2017
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendationsJessica E Haberer, Lora Sabin, K Rivet Amico, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2024
Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiationReneé de Waal, Kara Wools-Kaloustian, Ellen Brazier, et al.
Pageof 46

Showing results (441-450 of 458) with videos related to

Sort By:
Pageof 46
The Lancet. HIV|February 9, 2020
Updated assessment of risks and benefits of dolutegravir versus efavirenz in new antiretroviral treatment initiators in sub-Saharan Africa: modelling to inform treatment guidelinesAndrew N Phillips, Loveleen Bansi-Matharu, Francois Venter, et al.
The Lancet. HIV|October 2, 2015
Interventions to promote adherence to antiretroviral therapy in Africa: a network meta-analysisEdward J Mills, Richard Lester, Kristian Thorlund, et al.
The Pediatric Infectious Disease Journal|April 15, 2025
Global Trends in CD4 Measurement and Immunosuppression at ART Initiation Among Children With HIVGabriela Patten, Karen Malateste, Carolyn Bolton Moore, et al.
The Journal of Infectious Diseases|April 13, 2012
Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunitiesRuth McNerney, Markus Maeurer, Ibrahim Abubakar, et al.
Lancet (London, England)|August 4, 2012
Technologies for global healthPeter Howitt, Ara Darzi, Guang-Zhong Yang, et al.
The Lancet. Infectious Diseases|March 28, 2013
Drug-resistant tuberculosis: time for visionary political leadershipIbrahim Abubakar, Matteo Zignol, Dennis Falzon, et al.
The Lancet. HIV|December 2, 2021
Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countriesWin Min Han, Matthew G Law, Matthias Egger, et al.
Journal of the International AIDS Society|June 21, 2017
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendationsJessica E Haberer, Lora Sabin, K Rivet Amico, et al.
The Lancet. HIV|June 27, 2025
Evaluation of antiretroviral regimen switching options in adults with HIV with sustained viral load non-suppression on dolutegravir, lamivudine, and tenofovir in eastern, central, southern, and western Africa: a modelling studyAndrew N Phillips, Loveleen Bansi-Matharu, Joep J van Oosterhout, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 6, 2024
Global trends in CD4 count measurement and distribution at first antiretroviral treatment initiationReneé de Waal, Kara Wools-Kaloustian, Ellen Brazier, et al.
Pageof 46